Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

17.64 +0.44 (+2.56%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 870,675
Open 16.83
Bid (Size) 17.40 (100)
Ask (Size) 17.97 (100)
Prev. Close 17.20
Today's Range 16.80 - 17.77
52wk Range 16.60 - 28.47
Shares Outstanding 62,027,061
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as... 
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
News headline image
Schrödinger to Present at Jefferies London Healthcare Conference
From Schrödinger
Via Business Wire

Performance

YTD
-13.5%
-13.5%
1 Month
-14.4%
-14.4%
3 Month
-9.0%
-9.0%
6 Month
-25.2%
-25.2%
1 Year
-13.4%
-13.4%

More News

Read More
News headline image
Schrödinger Reports Third Quarter 2025 Financial Results
From Schrödinger
Via Business Wire
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Schrodinger ↗
Via Benzinga
News headline image
AI Unlocks Cosmic Secrets: Revolutionizing Discovery in Physics and Cosmology
Via TokenRing AI
Topics Artificial Intelligence
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Schrödinger to Announce Third Quarter 2025 Financial Results on November 5
From Schrödinger
Via Business Wire
Schrodinger Downgraded By Citi After Ending Blood Cancer Drug Trial Tied To 2 Deaths; Retail Voices Concern ↗
Via Stocktwits
Schrödinger Discontinues Clinical Program After Two Patient Deaths ↗
Via Stocktwits
News headline image
Earnings Scheduled For August 6, 2025 ↗
Via Benzinga
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
News headline image
Expert Outlook: Schrodinger Through The Eyes Of 5 Analysts ↗
Via Benzinga
News headline image
Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape
Via MarketMinute
Topics Animal Testing Artificial Intelligence Intellectual Property
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
News headline image
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
Via Benzinga
News headline image
This AZZ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
Via Benzinga
News headline image
Schrödinger Announces Discontinuation of SGR-2921 Program
From Schrödinger
Via Business Wire
News headline image
Schrödinger (SDGR) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Schrödinger Reports Second Quarter 2025 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6
From Schrödinger
Via Business Wire

Frequently Asked Questions

Is Schrodinger, Inc. - Common Stock publicly traded?
Yes, Schrodinger, Inc. - Common Stock is publicly traded.
What exchange does Schrodinger, Inc. - Common Stock trade on?
Schrodinger, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Schrodinger, Inc. - Common Stock?
The ticker symbol for Schrodinger, Inc. - Common Stock is SDGR on the Nasdaq Stock Market
What is the current price of Schrodinger, Inc. - Common Stock?
The current price of Schrodinger, Inc. - Common Stock is 17.64
When was Schrodinger, Inc. - Common Stock last traded?
The last trade of Schrodinger, Inc. - Common Stock was at 11/14/25 04:00 PM ET
What is the market capitalization of Schrodinger, Inc. - Common Stock?
The market capitalization of Schrodinger, Inc. - Common Stock is 1.09B
How many shares of Schrodinger, Inc. - Common Stock are outstanding?
Schrodinger, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.